| Entry |
|
|---|
| Name |
Aspirin trelamine (USAN) |
|---|
| Formula |
C15H21NO4
|
|---|
| Exact mass |
279.1471
|
|---|
| Mol weight |
279.3315
|
|---|
| Structure |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
|
|---|
| Remark |
| Product (DG00015): | D00109<JP> |
|
|---|
| Efficacy |
Analgesic, Anti-inflammatory, Antipyretic, Antirheumatic, Antiplatelet, COX inhibitor |
|---|
| Comment |
Treatment of diseases that are treated with aspirin, anti-inflammatory, analgesic, fever reduction, cardiovascular diseases, etc.
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A01 STOMATOLOGICAL PREPARATIONS
A01A STOMATOLOGICAL PREPARATIONS
A01AD Other agents for local oral treatment
A01AD05 Acetylsalicylic acid
D12595 Aspirin trelamine (USAN)
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC06 Acetylsalicylic acid
D12595 Aspirin trelamine (USAN)
N NERVOUS SYSTEM
N02 ANALGESICS
N02B OTHER ANALGESICS AND ANTIPYRETICS
N02BA Salicylic acid and derivatives
N02BA01 Acetylsalicylic acid
D12595 Aspirin trelamine (USAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00015 Acetylsalicylic acid
D12595 Aspirin trelamine
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
DG00015 Acetylsalicylic acid
D12595 Aspirin trelamine
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D12595 Aspirin trelamine (USAN)
PTGS2 (COX2)
D12595 Aspirin trelamine (USAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00015 Acetylsalicylic acid
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
DG00015 Acetylsalicylic acid
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C8y C 16.7674 -15.5798
2 C8y C 18.0249 -16.2785
3 C8x C 15.5797 -16.2785
4 C7a C 16.7674 -14.3223
5 C8x C 18.0249 -17.6757
6 O7a O 19.2126 -15.5100
7 C8x C 15.5797 -17.6757
8 O7a O 18.0249 -13.6236
9 O6a O 15.5797 -13.6236
10 C8x C 16.7674 -18.3744
11 C7a C 20.4702 -16.2086
12 C1a C 21.6579 -15.5100
13 O6a O 20.4702 -17.6757
14 C1b C 19.2108 -14.3352
15 C1b C 20.4050 -13.6723
16 N1c N 20.4286 -12.2500
17 C1b C 21.6612 -11.5654
18 C1a C 22.8321 -12.2676
19 C1b C 19.2363 -11.5350
20 C1a C 18.0167 -12.2125
BOND 20
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 4 8 1
8 4 9 2
9 5 10 1
10 6 11 1
11 11 12 1
12 11 13 2
13 7 10 2
14 8 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 16 19 1
20 19 20 1
|
|---|
